Metabolism of rutin and poncirin by human intestinal microbiota and cloning of their metabolizing α-L-rhamnosidase from Bifidobacterium dentium

Journal of Microbiology and Biotechnology

Volumn 25, Issue 1, 2015, Pages 18-25

  Bang, Seo Hyeon ^a   Hyun, Yang Jin ^a   Shim, Juwon ^a   Hong, Sung Woon ^a   Kim, Dong Hyun ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Bifidobacterium dentium; Gut microbiota; Metabolism; Poncirin; Rutin; Lrhamnosidase

Indexed keywords

4 NITROPHENYL ALPHA RHAMNOPYRANOSIDE; ALPHA RHAMNOSIDASE; AURANTIIN; BACTERIAL ENZYME; GINSENOSIDE RE; PLANT GLYCOSIDE; PONCIRIN; QUERCITRIN; RUTOSIDE; UNCLASSIFIED DRUG; ALPHA-L-RHAMNOSIDASE; FLAVANONE DERIVATIVE; FLAVONOID; GINSENOSIDE; GLYCOSIDASE; NITRILOTRIACETATE NICKEL; NITRILOTRIACETIC ACID; ORGANOMETALLIC COMPOUND; QUERCETIN;

ADULT; AGED; ALPHA RHAMNOSIDASE GENE; ARTICLE; BACTERIAL METABOLISM; BIFIDOBACTERIUM; BIFIDOBACTERIUM DENTIUM; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVITY; ENZYME SPECIFICITY; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION; HUMAN; HYDROLYSIS; INTESTINE FLORA; MALE; MOLECULAR CLONING; NONHUMAN; SEQUENCE ALIGNMENT; ANALOGS AND DERIVATIVES; BIOSYNTHESIS; CHEMISTRY; CLONING; GENETICS; INTESTINE; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MICROFLORA; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

BIFIDOBACTERIUM DENTIUM;

BASE SEQUENCE; BIFIDOBACTERIUM; CLONING, MOLECULAR; CLONING, ORGANISM; ESCHERICHIA COLI; FLAVANONES; FLAVONOIDS; GINSENOSIDES; GLYCOSIDE HYDROLASES; HUMANS; INTESTINES; MICROBIOTA; MOLECULAR SEQUENCE DATA; NITRILOTRIACETIC ACID; ORGANOMETALLIC COMPOUNDS; QUERCETIN; RUTIN; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; SUBSTRATE SPECIFICITY;

EID: 84921735608     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.1404.04060     Document Type: Article

References (29)

1. Avila M, Jaquet M, Moine D, Requena T, Pelaez C, Arigoni F, Jankovic I. 2009. Physiological and biochemical characterization of the two alpha-L-rhamnosidases of Lactobacillus plantarum NCC245. Microbiology 155: 2739-2749.
2. Beekwilder J, Marcozzi D, Vecchi S, de Vos R, Janssen P, Francke C, et al. 2009. Characterization of rhamnosidases from Lactobacillus plantarum and Lactobacillus acidophilus. Appl. Environ. Microbiol. 75: 3447-3454.
3. Crow JM. 2011. Microbiome: that healthy gut feeling. Nature 480: S88-S89.
4. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, et al. 2010. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. USA 107: 14691-14696.
5. Dihal AA, de Boer VC, van der Woude H, Tilburgs C, Bruijntjes JP, Alink GM, et al. 2006. Quercetin, but not its glycosidated conjugate rutin, inhibits azoxymethane-induced colorectal carcinogenesis in F344 rats. J. Nutr. 136: 2862-2867.
6. Goldin BR, Swenson L, Dwyer J, Sexton M, Gorbach SL. 19 80. E ffect o f diet a nd Lactobacillus acidophilus supplements on human fecal bacterial enzymes. J. Natl. Cancer Inst. 64: 255-261.
7. Hollman PC, Bijsman MN, van Gameren Y, Cnossen EP, de Vries JH, Katan MB. 1999. The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man. Free Radic. Res. 31: 569-573.
8. Ikeda N, Saito Y, Shimizu J, Ochi A, Mizutani J, Watabe J. 1994. Variations in concentrations of bacterial metabolites, enzyme activities, moisture, pH and bacterial composition between and within individuals in faeces of seven healthy adults. J. Appl. Bacteriol. 77: 185-194.
9. Jang IS, Kim DH. 1996. Purification and characterization of alpha-L-rhamnosidase from Bacteroides JY-6, a human intestinal bacterium. Biol. Pharm. Bull. 19: 1546-1549.
10. Joh EH, Lee IA, Jung IH, Kim DH. 2011. Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation-the key step of inflammation. Biochem. Pharmacol. 82: 278-286.
11. Kim D H, Bae E A, H an M J. 1 9 99. Anti-Helicobacter pylori activity of the metabolites of poncirin from Poncirus trifoliata by human intestinal bacteria. Biol. Pharm. Bull. 22: 422-424.
12. Lee NK, Choi SH, Park SH, Park EK, Kim DH. 2004. Antiallergic activity of hesperidin is activated by intestinal microflora. Pharmacology 71: 174-180.
13. Lee DS, Kim YS, Ko CN, Cho KH, Bae HS, Lee KS, et al. 2002. Fecal metabolic activities of herbal components to bioactive compounds. Arch. Pharm. Res. 25: 165-169.
14. Ling WH, Korpela R, Mykkanen H, Salminen S, Hanninen O. 1994. Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. J. Nutr. 124: 18-23.
15. Manach C, Morand C, Gil-Izquierdo A, Bouteloup-Demange C, Remesy C. 2003. Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. Eur. J. Clin. Nutr. 57: 235-242.
16. Manzanares P, Orejas M, Ibanez E, Valles S, Ramon D. 2000. Purification and characterization of an alpha-L-rhamnosidase from Aspergillus nidulans. Lett. Appl. Microbiol. 31: 198-202.
17. Mehrabani LV, Hassanpouraghdam MB. 2012. Developmental variation of phenolic compounds in fruit tissue of two apple cultivars. Acta Sci. Pol. Technol. Aliment. 11: 259-264.
18. Miake F, Satho T, Takesue H, Yanagida F, Kashige N, Watanabe K. 2000. Purification and characterization of intracellular alpha-L-rhamnosidase from Pseudomonas paucimobilis FP2001. Arch. Microbiol. 173: 65-70.
19. Michlmayr H, Brandes W, Eder R, Schumann C, del Hierro AM, Kulbe KD. 2011. Characterization of two distinct glycosyl hydrolase family 78 alpha-L-rhamnosidases from Pediococcus acidilactici. Appl. Environ. Microbiol. 77: 6524-6530.
20. Mikov M. 1994. The metabolism of drugs by the gut flora. Eur. J. Drug Metab. Pharmacokinet. 19: 201-207.
21. Mizuma T, Ohta K, Awazu S. 1994. The beta-anomeric and glucose preferences of glucose transport carrier for intestinal active absorption of monosaccharide conjugates. Biochim. Biophys. Acta 1200: 117-122.
22. Mykkanen H, Laiho K, Salminen S. 1998. Variations in faecal bacterial enzyme activities and associations with bowel function and diet in elderly subjects. J. Appl. Microbiol. 85: 37-41.
23. Park HY, Bae EA, Han MJ, Choi EC, Kim DH. 1998. Inhibitory effects of Bifidobacterium spp. isolated from a healthy Korean on harmful enzymes of human intestinal microflora. Arch. Pharm. Res. 21: 54-61.
24. Reddy BS, Hanson D, Mangat S, Mathews L, Sbaschnig M, Sharma C, Simi B. 1980. Effect of high-fat, high-beef diet and of mode of cooking of beef in the diet on fecal bacterial enzymes and fecal bile acids and neutral sterols. J. Nutr. 110: 1880-1887.
25. Scheline RR. 1973. Metabolism of foreign compounds by gastrointestinal microorganisms. Pharmacol. Rev. 25: 451-523.
26. Shin YW, Bae EA, Kim SS, Lee YC, Lee BY, Kim DH. 2006. The effects of ginsenoside Re and its metabolite, ginsenoside Rh1, on 12-O-tetradecanoylphorbol 13-acetate-and oxazoloneinduced mouse dermatitis models. Planta Med. 72: 376-378.
27. Simon GL, Gorbach SL. 1986. The human intestinal microflora. Dig. Dis. Sci. 31: 147S-162S.
28. Yanai T, Sato M. 2000. Purification and characterization of an alpha-L-rhamnosidase from Pichia angusta X 349. Biosci. Biotechnol. Biochem. 64: 2179-2185. 29. Yu KU, Jang I S, K ang KH, Sung C K, K im D H. 1 9 9. 7 Metabolism of saikosaponin c and naringin by human intestinal bacteria. Arch. Pharm. Res. 20: 420-424.
29. Zverlov VV, Hertel C, Bronnenmeier K, Hroch A, Kellermann J, Schwarz WH. 2000. The thermostable alpha-Lrhamnosidase RamA of Clostridium stercorarium: biochemical characterization and primary structure of a bacterial alpha-lrhamnoside hydrolase, a new type of inverting glycoside hydrolase. Mol. Microbiol. 35: 173-179.